Indivior Pharmaceuticals (INDV) Return on Sales [ROS] (2024 - 2026)
Indivior Pharmaceuticals (INDV) reported Return on Sales [ROS] of 46.65% for Q2 2026, up 22.81 percentage points from 23.84% a year earlier and up 3.43 percentage points from the prior quarter.
Powered by 
Analysis
Indivior Pharmaceuticals (INDV) Return on Sales [ROS] (2024 - 2026) Analysis & Trends
Over the twelve months ended Jun 30, 2026, Indivior Pharmaceuticals' Return on Sales [ROS] came in at 31.61%, up 12.95 percentage points year-over-year; for FY2025, it was 21.15%, up 17.95 percentage points from FY2024.
- Return on Sales [ROS] has a four-year change of -5.78 percentage points (FY2021 to FY2025).
- By year, Return on Sales [ROS] came in at 3.20% in FY2024 (+17.11 pp), -13.91% in FY2023 (-5.36 pp), -8.55% in FY2022 (-35.47 pp) and 26.93% in FY2021.
- The Q2 2026 figure ranks as the highest quarterly Return on Sales [ROS] in data going back to Q1 2024.
- Year over year, Return on Sales [ROS] has now increased in each of the last five quarters, with an average year-over-year change of +18.74 percentage points over the last six quarters.
- Per Business Quant data, the three quarters before Q2 2026 came in at 43.22% (Q1 2026), 22.63% (Q4 2025) and 13.69% (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROS (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 51.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 28.21% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 37.86% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | -3.52% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 32.97% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 20.57% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 34.95% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -133.21% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 28.37% |
| 10 | Indivior Pharmaceuticals | 4.21 Bn | 3.18 Bn | 294.00 Mn | 46.65% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 46.65% |
| Mar 31, 2026 | 43.22% |
| Dec 31, 2025 | 22.63% |
| Sep 30, 2025 | 13.69% |
| Jun 30, 2025 | 23.84% |
| Mar 31, 2025 | 24.81% |
| Dec 31, 2024 | 15.38% |
| Sep 30, 2024 | 11.40% |
| Jun 30, 2024 | -39.46% |
| Mar 31, 2024 | 26.41% |
API Access
Indivior Pharmaceuticals Return on Sales [ROS] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INDV&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-sales-[ros]", "ticker": "INDV", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-sales-%5Bros%5D&ticker=INDV&period=max&api_key=YOUR_API_KEY");
const data = await res.json();